(Q40712034)

English

Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) after chemotherapy in patients with non-Hodgkin's lymphoma; a placebo-controlled double blind phase III trial

scientific article published on October 1993

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) after chemotherapy in patients with non-Hodgkin's lymphoma; a placebo-controlled double blind phase III trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

Colony stimulating factor 2

1 reference

based on heuristic

inferred from title

author name string

Kaku K

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Takahashi M

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Moriyama Y

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Nakahata T

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Masaoka T

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Yoshida Y

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Shibata A

7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Kaneko T

8

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Miwa S

9

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

publication date

1 October 1993

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

3-4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

229-238

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Granulocytopenia and cancer therapy. Past problems, current solutions, future challenges

1 reference

https://api.crossref.org/works/10.3109%2F10428199309087000

21 January 2018

Hematopoietic growth factors. Biology and clinical applications

1 reference

https://api.crossref.org/works/10.3109%2F10428199309087000

21 January 2018

Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival

1 reference

https://api.crossref.org/works/10.3109%2F10428199309087000

21 January 2018

Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins

1 reference

https://api.crossref.org/works/10.3109%2F10428199309087000

21 January 2018

Isolation of cDNA for a human granulocyte-macrophage colony-stimulating factor by functional expression in mammalian cells

1 reference

https://api.crossref.org/works/10.3109%2F10428199309087000

21 January 2018

Genomic cloning, characterization, and multilineage growth-promoting activity of human granulocyte-macrophage colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.3109%2F10428199309087000

21 January 2018

Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy

1 reference

https://api.crossref.org/works/10.3109%2F10428199309087000

21 January 2018

Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428199309087000

21 January 2018

Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever

1 reference

https://api.crossref.org/works/10.3109%2F10428199309087000

21 January 2018

Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.3109%2F10428199309087000

21 January 2018

Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium

1 reference

https://api.crossref.org/works/10.3109%2F10428199309087000

21 January 2018

Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy. The Multicenter Study Group

1 reference

https://api.crossref.org/works/10.3109%2F10428199309087000

21 January 2018

Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator

1 reference

https://api.crossref.org/works/10.3109%2F10428199309087000

21 January 2018

Identifiers

10.3109/10428199309087000

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40712034&oldid=1905009233"